Clinical Trial

A Study of Xevinapant With Cisplatin and Radiation Therapy After Surgery in People With Head and Neck Cancer

Completed Phase 2
View on ClinicalTrials.gov →
Summary
The purpose of this study is to test whether treatment with Xevinapant added to standard chemoradiation after surgery is an effective treatment for people with high-risk head and neck cancers.
Protocol Amendment History 3 changes
critical Trial completed 2026-08-11
notable Primary completion moved earlier: 2026-11 -> 2026-08-04 2026-08-11
minor Completion moved earlier: 2026-11 -> 2026-08-04 2026-08-11
Trial Details
NCT Number NCT06145412
Lead Sponsor Memorial Sloan Kettering Cancer Center
Conditions Head and Neck Cancer
Enrollment 4 participants
Start Date 2023-11-16
Primary Completion 2026-08-04 (estimated)
Study Completion 2026-08-04 (estimated)
Updated on ClinicalTrials.gov 2026-08-10